nach oben

Drugs & Aging

Erschienen in:

01.06.2005 | Review Article

Influenza Vaccination in the Elderly

Impact on Hospitalisation and Mortality

verfasst von: Dr Kristin L. Nichol

Erschienen in: Drugs & Aging | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Abstract

Influenza causes substantial morbidity across the age spectrum. However, the elderly are especially vulnerable to the serious complications of influenza that might result in hospitalisation or death, and high rates of influenza-associated excess hospitalisation or death that exceed by several-fold the rates seen among most other age groups have consistently been observed in many countries and across many seasons. Thus, the elderly are included among the high priority groups for routine influenza vaccination by many national health authorities.

Inactivated influenza virus vaccines are widely available across the globe and are safe and effective. Vaccination of elderly persons has been associated with significant reductions in hospitalisations for pneumonia and influenza as well as hospitalisations for other cardiopulmonary disorders and even cerebrovascular disease. Vaccination has also been associated with reductions in influenza-associated and all-cause mortality during influenza seasons. The benefits of vaccination extend not only to community-dwelling elderly but also to elderly who reside in nursing homes. Likewise, vaccination provides benefits to the very old and to elderly persons with underlying co-morbidities as well as to the healthy elderly.

Despite the substantially increased risk for serious complications and impressive benefits from vaccination among the elderly, influenza vaccine utilisation remains below target rates for this group in nearly all countries. The need for improved prevention and control of influenza is recognised as a priority for the global community — both to reduce the morbidity and mortality associated with epidemic influenza and to prepare for the next pandemic. Enhancing vaccine delivery to elderly persons would represent important progress toward that goal.

The use of trade names is for product identification purposes only and does not imply endorsement.

Couch RB. Advances in influenza virus vaccine research. Ann N Y Acad Sci 1993; 685: 802–12CrossRef

World Health Organization. Influenza vaccines. Wkly Epidemiol Rec 2000; 75: 281–8

Kavet J. A perspective on the significance of pandemic influenza. Am J Public Health 1977; 67: 1063–70PubMedCrossRef

Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2004; 53(RR-6): 1–40

Barker WH, Borisute H, Cox C. A study of the impact of influenza on the functional status of frail older people. Arch Intern Med 1998; 158: 645–50PubMedCrossRef

World Health Organization. Influenza vaccines. Wkly Epidemiol Rec 2002; 77: 229–40

Van Essen GA, Palache AM, Forleo E, et al. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003; 21: 1780–5PubMedCrossRef

Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292: 1333–40PubMedCrossRef

McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Arch Intern Med 1993; 153: 2105–11PubMedCrossRef

10.

Baltussen RMPM, Reinders A, Sprenger MJW, et al. Estimating influenza-related hospitalization in The Netherlands. Epidemiol Infect 1998; 121: 129–38PubMedCrossRef

11.

Upshur REG, Goel V. Measuring the impact of influenza on the hospitalization rates of the elderly in Ontario: a five-year admission rate analysis, 1988–1993. Can J Public Health 2000; 91: 144–7PubMed

12.

Simonsen L, Fukuda K, Schonberger LB, et al. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000; 181(3): 831–7PubMedCrossRef

13.

Nguyen-Van-Tam JS, Brockway CR, Pearson JCG, et al. Excess hospital admissions for pneumonia and influenza in persons ≥65 years associated with influenza epidemics in three English health districts: 1987–95. Epidemiol Infect 2001; 126: 71–9PubMedCrossRef

14.

Scuffham PA. Estimating influenza-related hospital admissions in older people from GP consultation data. Vaccine 2004; 22: 2853–62PubMedCrossRef

15.

McBean AM, Hebert PL. New estimates of influenza-related pneumonia and influenza hospitalizations among the elderly. Int J Infect Dis 2004; 8: 227–35PubMedCrossRef

16.

Menec VH, Black C, MacWilliam L, et al. The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality. Can J Public Health 2003; 94(1): 59–63PubMed

17.

Menec VH, MacWilliam L, Aoki FY. Hospitalizations and deaths due to respiratory illnesses during influenza seasons: a comparison of community residents, senior housing residents, and nursing home residents. J Gerontol 2002; 57A(10): M629–35

18.

Ellis SE, Coffey CS, Mitchel Jr EF, et al. Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population. J Am Geriatr Soc 2003; 51: 761–7PubMedCrossRef

19.

Fleming D, Harcourt S, Smith G. Influenza and adult hospital admissions for respiratory conditions in England 1989–2001. Commun Dis Public Health 2003; 6: 231–7PubMed

20.

Yap FHY, Ho P, Lam K, et al. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol 2004; 73: 617–23PubMedCrossRef

21.

Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179–86PubMedCrossRef

22.

Simonsen L, Clarke MJ, Schonberger LB, et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998; 178: 53–60PubMedCrossRef

23.

Carrat F, Valleron A. Influenza mortality among the elderly in France, 1980–1990: how many deaths may have been avoided through vaccination? J Epidemiol Community Health 1995; 49: 419–25PubMedCrossRef

24.

Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342: 232–9PubMedCrossRef

25.

Neuzil KM, Meilen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342: 225–31PubMedCrossRef

26.

Chiu SS, Lau YL, Chan KH, et al. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med 2002; 347: 2097–103PubMedCrossRef

27.

Hak E, Wei F, Nordin J, et al. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis 2004; 189: 450–8PubMedCrossRef

28.

Margolis KL, Nichol KL, Poland GA, et al. Frequency of adverse reactions to influenza vaccine in the elderly: a randomized, placebo-controlled trial. JAMA 1990; 264: 1139–41PubMedCrossRef

29.

Govaert TME, Aretz K, Masurel N, et al. Adverse reactions to influenza vaccine in elderly people: a randomised double blind placebo controlled trial. BMJ 1993; 307: 988–90PubMedCrossRef

30.

Allsup SJ, Gosney M, Regan M, et al. Side effects of influenza vaccination in healthy older people: a randomised single-blind placebo-controlled trial. Gerontology 2001; 47: 311–4PubMedCrossRef

31.

Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH, et al. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet 1998; 351: 326–31PubMedCrossRef

32.

American Lung Association Asthma Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 2001; 345: 1529–36CrossRef

33.

Tata LJ, West J, Harrison T, et al. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax 2003; 58: 835–9PubMedCrossRef

34.

Lasky T, Terracciano GJ, Magder L, et al. The Guillain-Barre syndrome and the 1992–1993 and 1993–1994 influenza vaccines. N Engl J Med 1998; 339: 1797–802PubMedCrossRef

35.

Immunization Safety Review Committee. Institute of Medicine. Immunization safety review. Influenza vaccines and neurological complications. Washington, DC: The National Academies Press, 2004

36.

National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004–2005 season. Can Commun Dis Rep 2004; 30(ACS-3): 1–32

37.

Provinciali M, Di Stefano G, Muzzioli M, et al. Impaired antibody response to influenza vaccine in institutionalized elderly. Ann N Y Acad Sci 1994; 717: 307–14PubMedCrossRef

38.

McElhaney JE, Upshaw CM, Hooton JW, et al. Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults. Vaccine 1998; 16: 1742–7PubMedCrossRef

39.

Deng Y, Jing Y, Campbell AE, et al. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 2004; 172: 3437–46PubMed

40.

Gross PA, Quinnan GV, Weksler ME, et al. Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine 1989; 7: 303–8PubMedCrossRef

41.

Muszkat M, Friedman G, Dannenberg HD, et al. Response to influenza vaccination in community and in nursing home residing elderly: relation to clinical factors. Exp Gerontol 2003; 38: 1199–203PubMedCrossRef

42.

Fulop Jr T, Wagner JR, Khalil A, et al. Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects. J Gerontol 1999; 54A: M59–64

43.

Beyer WEO, Palache AM, Baljet M, et al. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine 1989; 7: 385–4PubMedCrossRef

44.

Carson PJ, Nichol KL, O’Brien J, et al. Immune function and vaccine responses in healthy advanced elderly patients. Arch Intern Med 2000; 160: 2017–24PubMedCrossRef

45.

Gross PA, Weksler ME, Quinnan GV, et al. Immunization of elderly people with two doses of influenza vaccine. J Clin Microbiol 1987; 25: 1763–5PubMed

46.

Gross PA, Quinnan Jr GV, Weksler ME, et al. Immunization of elderly people with high doses of influenza vaccine. J Am Geriatr Soc 1988; 36: 209–12PubMed

47.

Govaert TME, Thijs CTMCN, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661–5PubMedCrossRef

48.

Wongsurakiat P, Maranetra KN, Wasi C, et al. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004; 125: 2011–20PubMedCrossRef

49.

Nicholson KG, Kent J, Hammersley V. Influenza A among community-dwelling elderly persons in Leicestershire during winter 1993–94; cigarette smoking as a risk factor and the efficacy of influenza vaccination. Epidemiol Infect 1999; 123: 103–8PubMedCrossRef

50.

Voordouw BCG, van der Linder PD, Simonian S, et al. Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Arch Intern Med 2003; 163: 1089–94PubMedCrossRef

51.

Allsup S, Haycox A, Regan M, et al. Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trial. Vaccine 2004; 23: 639–45PubMed

52.

Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778–84PubMedCrossRef

53.

Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998; 158: 1769–76PubMedCrossRef

54.

Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis 2001; 184: 665–70PubMedCrossRef

55.

Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348: 1322–32PubMedCrossRef

56.

Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994; 121: 947–52PubMed

57.

Fedson DS, Wajda A, Nicol JP, et al. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993; 270: 1965–1CrossRef

58.

Foster DA, Talsma A, Furomoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992; 136: 296–306PubMed

59.

Ohmit SE, Monto AS. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemiol 1995; 24: 1240–8PubMedCrossRef

60.

Stamboulian D, Bonvehi PE, Nacinovich FM, et al. Immunization against influenza in the elderly: the Argentinian experience, 1993–1997. Vaccine 1999 Jul 30; 17Suppl. 1: S53–6PubMedCrossRef

61.

Crocetti E, Arniani S, Bordoni F, et al. Effectiveness of influenza vaccination in the elderly in a community in Italy. Eur J Epidemiol 2001; 17: 163–8PubMedCrossRef

62.

Puig-Barbera J, Marquez-Calderon S, Masoliver-Fores A, et al. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. J Epidemiol Community Health 1997; 51: 526–30PubMedCrossRef

63.

Davis JW, Lee E, Taira DA, et al. Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Med Care 2001; 39: 1273–80PubMedCrossRef

64.

Ahmed AH, Nicholson KG, Nguyen-Van-Tam JS, et al. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989–90 epidemic. Epidemiol Infect 1997; 118: 27–33PubMedCrossRef

65.

Mangtani P, Cumberland P, Hodgson CR, et al. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 2004; 190: 1–10PubMedCrossRef

66.

Lavallee P, Perchaud V, Gautier-Bertrand M, et al. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002; 33: 513–8PubMedCrossRef

67.

Siscovick DS, Raghunathan TE, Lin D, et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000; 152: 674–7PubMedCrossRef

68.

Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102: 3039–45PubMedCrossRef

69.

Gurfinkel EP, de la Fuente RL, Mendiz O, et al. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) study: one-year follow-up. Eur Heart J 2004; 25: 25–31PubMedCrossRef

70.

Jackson LA, Yu O, Heckbert SR, et al. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002; 156: 634–40PubMedCrossRef

71.

Wang C, Wang S, Chou P. Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community. Vaccine 2002; 20: 2494–9PubMedCrossRef

72.

Shapiro Y, Shemer J, Heymann A, et al. Influenza vaccination: reduction in hospitalizations and death rates among members of ‘Maccabi Healthcare Services’ during the 2000–2001 influenza season. Isr Med Assoc J 2003; 5: 706–9PubMed

73.

Wang CS, Wang ST, Lai CT, et al. Reducing major causespecific hospitalization rates and shortening hospital stays after influenza vaccination. Clin Infect Dis 2004; 39: 1604–10PubMedCrossRef

74.

Nichol KL. Complications of influenza and benefits of vaccination. Vaccine 1999; 17Suppl. 1: S47–52PubMedCrossRef

75.

Fleming DM, Watson JM, Nicholas S, et al. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989–90 using a general practice database. Epidemiol Infect 1995; 115: 581–9PubMedCrossRef

76.

Landi F, Onder G, Cesari M, et al. Effects of influenza vaccination on mortality among frail, community-living elderly patients: an observational study. Aging Clin Exp Res 2003; 15: 254–8PubMed

77.

Armstrong BG, Mangtani P, Fletcher A, et al. Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people. BMJ 2004; 329: 660PubMedCrossRef

78.

Voordouw ACG, Sturkenboom MCJM, Dieleman JP, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA 2004; 292: 2089–95PubMedCrossRef

79.

Ahmed AEH, Nicholson KG, Nguyen-Van-Tam JS. Reduction in mortality associated with influenza vaccine during 1989–90 epidemic. Lancet 1995; 346: 591–5PubMedCrossRef

80.

Vu T, Farish S, Jenkins M, et al. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002; 20: 1831–6PubMedCrossRef

81.

Hak E, Nordin J, Wei F, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis 2003; 35: 370–7CrossRef

82.

Herzog NS, Bratzier DW, Houck PM, et al. Effects of previous influenza vaccination on subsequent readmission and mortality in elderly patients hospitalized with pneumonia. Am J Med 2003; 115: 454–61PubMedCrossRef

83.

Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999; 130: 397–403PubMed

84.

Schade CP, McCombs MA. Influenza immunization and mortality among diabetic Medicare beneficiaries in West Virginia. W V Med J 2000; 96: 444–8PubMed

85.

Strassburg MA, Greenland S, Sorvillo FJ, et al. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986; 4: 38–44PubMedCrossRef

86.

Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995; 123: 518–27PubMed

87.

Ohmit SE, Arden NH, Monto AS. Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic. J Am Geriatr Soc 1999; 47: 165–71PubMed

88.

Deguchi Y, Takasugi Y, Nishimura K. Vaccine effectiveness for influenza in the elderly in welfare nursing homes during an influenza A (H3N2) epidemic. Epidemiol Infect 2000; 125: 393–7PubMedCrossRef

89.

Saito R, Suzuki H, Oshitani H, et al. The effectiveness of influenza vaccine against influenza A (H3N2) virus infections in nursing homes in Niigata, Japan, during the 1998–1999 and 1999–2000 seasons. Infect Control Hosp Epidemiol 2002; 23: 82–6PubMedCrossRef

90.

Monto AS, Hombuckle K, Ohmit SE. Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. Am J Epidemiol 2001; 154: 155–60PubMedCrossRef

91.

Centers for Disease Control and Prevention. Update: influenza activity: United States, 1997–98 season. MMWR Morb Mortal Wkly Rep 1998; 47: 196–200

92.

Health Canada. Effectiveness of inactivated trivalent influenza vaccine in long-term care institutions, Toronto, 2003–2004. Can Commun Dis Rep 2004; 30: 109–16

93.

Loeb M, McGeer A, McArthur M, et al. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999; 159: 2058–64PubMedCrossRef

94.

Rudenko LG, Arden NH, Grigorieva E, et al. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine 2001; 19: 308–18CrossRef

95.

Nichol KL. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 2001; 161: 749–59PubMedCrossRef

96.

De Jong JC, Beyer WEP, Palache AM, et al. Mismatch between the 1997–1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 2000; 61: 94–9PubMedCrossRef

97.

Centers for Disease Control and Prevention. Preliminary assessment of the effectiveness of the 2003–04 inactivated influenza vaccine: Colorado, December 2003. MMWR Morb Mortal Wkly Rep 2004; 53: 8–11

98.

Centers for Disease Control and Prevention. Assessment of the effectiveness of the 2003–04 influenza vaccine among children and adults: Colorado, 2003. MMWR Morb Mortal Wkly Rep 2004; 53: 707–10

99.

Nichol KL. Live attenuated influenza virus vaccines: new options for the prevention of influenza. Vaccine 2001; 19: 4373–7PubMedCrossRef

100.

Targonski PV, Poland GA. Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly? Drugs Aging 2004; 21: 349–59PubMedCrossRef

101.

Treanor JJ, Mattison HR, Dumyati G, et al. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med 1992; 117: 625–33PubMed

102.

Gorse GJ, O’Connor TZ, Young SL, et al. Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study. Vaccine 2003; 21: 2142–53CrossRef

103.

Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 1999; 17: S91–3PubMedCrossRef

104.

Christenson B, Hedlund J, Lundbergh P, et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur J Respir Dis 2004; 23: 363–8CrossRef

105.

Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997; 175: 1–6PubMedCrossRef

106.

Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000; 355: 93–7PubMedCrossRef

107.

Arden N, Monto AS, Ohmit SE. Vaccine use and the risk of outbreaks in a sample of nursing homes during an influenza epidemic. Am J Public Health 1995; 85: 399–401PubMedCrossRef

108.

Reichert TA, Sugaya N, Fedson DS, et al. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001; 344: 889–96PubMedCrossRef

109.

Jin Y, Carriere KC, Predy G, et al. The association between influenza immunization coverage rates and hospitalization for community-acquired pneumonia in Alberta. Can J Public Health 2003; 94: 341–5PubMed

110.

Simonsen L, Reichert TA, Vibound C, et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 2005; 165: 265–72PubMedCrossRef

111.

Nichol KL. The efficacy, effectiveness, and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 2003; 21: 1769–75PubMedCrossRef

112.

Stohr K. The global agenda on influenza surveillance and control. Vaccine 2003; 21: 1744–8PubMedCrossRef

Titel: Influenza Vaccination in the Elderly
Impact on Hospitalisation and Mortality
verfasst von: Dr Kristin L. Nichol
Publikationsdatum: 01.06.2005
Verlag: Springer International Publishing
Erschienen in: Drugs & Aging / Ausgabe 6/2005
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI: https://doi.org/10.2165/00002512-200522060-00004

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2005

Reducing the Risk of Stroke in Elderly Patients with Hypertension

Adenosine A2A Receptor Antagonists for Parkinson’s Disease

Late-Onset Ankylosing Spondylitis and Related Spondylarthropathies

Poststroke Dementia in the Elderly